T-O (am): 0.240 (08:59:00)
T-O (pm): 0.235 (14:29:00)
Last updated: 14:47
Customize
Select columns required and click "Update" to save your preferences
EPS | 9.15 sen |
Trailing PE (Sector Median: 17.8) | 2.6 |
PEG | 0.27 |
Altman Z | 1.1 |
Beaver | -0.024 |
Current Ratio | 0.59 |
Debt-Equity (DE) Ratio | -8.49 |
FCF Yield | -18.5 % |
Revenue QoQ | -10.04 % |
Revenue YoY | 17.3% |
Profit QoQ | -97.68 % |
Profit YoY | 107.17 % |
Profit Margin (Sector Median: 2.2) | 3.51 % |
ROE (ROIC: 37.08) | 20.01 % |
Dividend Per Share (DPS) | 0.0 sen |
Dividend Yield (DY) | 0.0 % |
Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports
EPS | |
Trailing PE (Sector Median: 17.8) | |
Profit QoQ | |
Profit YoY | |
Profit Margin (Sector Median: 2.2) | |
ROE (ROIC: 37.2) | |
Altman Z |
Discounted Cash Flow (DCF) 5% Growth | |
Discounted Cash Flow (DCF) 10% Growth | |
Relative Valuation | |
Average Analysts FV based on 1 rating(s) |
Graham Formula | |
Graham Number | |
Net Tangible Asset (NTA) | -0.12 |
Consistent QR FV |
Forward PE FV Calculator | |
Latest Profit (adjusted) [M] | 2.35 |
Expected Profit (Next QR) [M] | |
Expected Profit (After QR above) [M] | |
Expected Profit (After QR above) [M] | |
Estimated Fair Value |
Growth/Risk Fair Value Calculator | |
Expected growth (%) | |
Estimated downside / risk (%) | |
Estimated New DCF Fair Value |
Contract/Award Contribution Calculator | |
Contract/Award Value (in Million) | |
Estimated Contribution to Stock Price | |
Estimated New DCF Fair Value |
Profit-Based Calculator | |
Expected Profit (M) | |
for Year | |
Estimated New DCF Fair Value |
Revenue-Based Calculator | |
Expected Revenue (M) | |
for Year | |
Estimated New DCF Fair Value |
Market Pricing | |
Expected Profit (M) | 330.12 |
Expected Revenue (M) | 31439.92 |
Expected Growth (%) | 38.0 |
No transaction in the last 2 months.
Market Cap: 338 M.
Market Cap Class: Small caps
Number of Shares: 1441 M.
Adjusted Float: 39.5%.
Stock highly correlated with
AIMFLEX (84%)
DSS (83%)
AYS (79%)
COASTAL (79%)
Pharmaniaga Berhad, through its subsidiaries, operates as an integrated healthcare company. It is engaged in the logistics and distribution; sale and marketing; and research, development, and manufacture of generic pharmaceuticals, as well as the supply of medical products and services; hospital equipping; and provision of information technology solutions. It is also involved in the sale and distribution of portable medical devices; contract manufacturing; and distribution and trade of pharmaceuticals products, food supplements, and diagnostics products. Pharmaniaga sells its products and services to the public and private sectors primarily in Malaysia and Indonesia. The company was founded in 1994 and is based in Shah Alam, Malaysia. Pharmaniaga Bhd operates as a member of UEM Group.
Sectors: Trading & Services, Healthcare, Pharmaceuticals, Vaccine, Penny Stocks
Code: 7081
Website: http://www.pharmaniaga.com/
Related Links: Bursa | Annual Report | Announcement
No warrants listed
Updated on 31-Mar-2023
Shareholder | % | Value (M) |
---|---|---|
Boustead Holdings Berhad | 51.84% | 175.58 |
Lembaga Tabung Angkatan Tentera | 8.62% | 29.19 |
East Navigators Capital Ltd | 4.19% | 14.18 |
Dasar Technologies Sdn Bhd | 0.74% | 2.51 |
Lew U Sing | 0.63% | 2.13 |
Che Lodin Bin Wok Kamaruddin | 0.47% | 1.59 |
Yong Siew Yoon | 0.31% | 1.05 |
Public Gold Marketing Sdn Bhd | 0.3% | 1.02 |
Lembaga Tabung Amanah Melaka | 0.27% | 0.91 |
Poh Seng Kian | 0.27% | 0.91 |
Celeste Resources Sdn Bhd | 0.23% | 0.78 |
Ahmad Johari Bin Abdul Razak | 0.23% | 0.78 |
Teng Chi Lik | 0.23% | 0.78 |